Effect of Alpinia officinarum on the Formation of Advanced Glycation Endproducts and Aldose Reductase Activity

  • Lim, Soon-Sung (Department of Food Science and Nutrition, Center for Efficacy Assessment and Development of Functional Foods and Drugs (RIC), Hallym University) ;
  • Kim, Hye-Mi (Department of Food Science and Nutrition, Center for Efficacy Assessment and Development of Functional Foods and Drugs (RIC), Hallym University) ;
  • Kim, Sun-Young (Department of Food Science and Nutrition, Center for Efficacy Assessment and Development of Functional Foods and Drugs (RIC), Hallym University) ;
  • Jeon, Young-Eun (Department of Food Science and Nutrition, Center for Efficacy Assessment and Development of Functional Foods and Drugs (RIC), Hallym University) ;
  • Lee, Yeon-Sil (Department of Food Science and Nutrition, Center for Efficacy Assessment and Development of Functional Foods and Drugs (RIC), Hallym University) ;
  • Kang, Il-Jun (Department of Food Science and Nutrition, Center for Efficacy Assessment and Development of Functional Foods and Drugs (RIC), Hallym University)
  • Published : 2009.02.28

Abstract

The inhibition effects of an Alpinia officinarum (AO, Zingiberaceae) on the formation of advanced glycation end products, aldose reductase, and scavenging effect on 1,1-diphenyl-2-picryl-hydrazil (DPPH) radical for the prevention and/or treatment of diabetic complications were investigated. The ethyl acetate fraction of AO was the most effective among all fractions. Through the tests with electron impact-mass spectrometry and nuclear magnetic resonance, two compounds (compound 1 and 2) finally obtained from the ethyl acetate fraction of AO were identified as galangin (1) and kaempferide (2), respectively. In addition, the compound 1 and 2 and the ethyl acetate fraction were compared for the prevention effect on advanced glycation end products, aldose reductase, and the scavenging effect on DPPH radical. The ethyl acetate fraction was significantly more effective than the 2 compounds for those preventive activities.

Keywords

References

  1. Yamagishi S, Imaizumi T. Diabetic vascular complications:Pathophysiology, biochemical basis, and potential therapeutic strategy. Curro Pharm. Design 11: 2279-2299 (2005) https://doi.org/10.2174/1381612054367300
  2. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. 5: 561-568 (2002) https://doi.org/10.1097/00075197-200209000-00016
  3. Wen Y, Skidmore JC, Porter-Turner MM, Rea CA, Khokher MA, Singh BM. Relationship of glycation, antioxidant status, and oxidative stress to vascular endothelial damage in diabetes. Diabetes Obes. Metab. 4: 305-308 (2002) https://doi.org/10.1046/j.1463-1326.2002.00212.x
  4. Wolff SP, Jiang ZY, Hunt JV Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radical Bio. Med. 10: 339-352 (1991) https://doi.org/10.1016/0891-5849(91)90040-A
  5. McCance DR, Dyer DG, Dunn JA, Baiue KE, Thorpe SR, Baynes JW, Lyons TJ. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J. Clin. Invest. 91: 2470-2478 (1993) https://doi.org/10.1172/JCI116482
  6. Brownlee M, Cerami A, Viassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl. J. Med. 318: 1315-1321 (1988) https://doi.org/10.1056/NEJM198805193182007
  7. Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pr. 67: 3-21 (2005) https://doi.org/10.1016/j.diabres.2004.09.004
  8. Vasan S, Zhang X, Kapurniotu A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Slih D, Terlecky I, Bucala R, Cerami A, Egan J, Ulrich P. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382: 275-278 (1996) https://doi.org/10.1038/382275a0
  9. Rahbar S, Figarola JL. Novel inhibitors of advanced glycation endproducts. Arch. Biochem. Biophys. 419: 63-79 (2003) https://doi.org/10.1016/j.abb.2003.08.009
  10. Kador PF. The role of aldose reductase in the development of diabetic complications. Med. Res. Rev. 8: 325-352 (1988) https://doi.org/10.1002/med.2610080302
  11. Enomoto S, Okada Y, Guvenc A, Erdurak CS, Coskun M, Okuyama T. Inhibitory effects of traditional Turkish folk medicines on aldose reductase (AR) and hematological activity, and on AR inhibitory activity of quercetin-3-0-methyl ether isolated from Cistus laurijolius L. BioI. Pharm. Bull. 27: 1140-1143 (2004) https://doi.org/10.1248/bpb.27.1140
  12. Lee YS, Lee S, Lee HS, Kim BK, Ohuchi K, Shin KH. Inhibitory effects of isorhamnetin-3-O-$\beta$-D-glucoside from Salicornia herbacea on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. BioI. Pharm. Bull. 28:916-918 (2005) https://doi.org/10.1248/bpb.28.916
  13. Itokawa H, Morita H, Midorikawa I, Alyama R, Morita M. Diarylheptanoids from the rhizome of Alpinia officinarum Hance. Chem. Pharm. Bull. 33: 4889-4893 (1985) https://doi.org/10.1248/cpb.33.4889
  14. Itokawa H, Morita M, Mihashi S. The new diarylheptanoids from Alpinia officinarum Hance. Chem. Pharm. Bull. 29: 2383-2385 (1981) 15. Shin JE, Han MJ, Kim DH. 3-Methylethergalangin isolated from Alpinia officinarum inhibits pancreatic lipase. BioI. Pharm. Bull. 26:854-857 (2003) https://doi.org/10.1248/bpb.26.854
  15. Shin JE, Han MJ, Kim DH. 3-Methylethergalangin isolated from Alpinia officinarum inhibits pancreatic lipase. BioI. Pharm. Bull. 26:854-857 (2003) https://doi.org/10.1248/bpb.26.854
  16. Tao L, Wang ZT, Zhu EY, Lu YH, Wei DZ. HPLC analysis of bioactive flavonoids from the rhizome of Alpinia officinarum. S. Afr. J. Bot. 72: 163-166 (2006) https://doi.org/10.1016/j.sajb.2005.06.007
  17. Heo MY, Sohn SJ, Au WW. Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat. Res. 488: 135-150 (2001) https://doi.org/10.1016/S1383-5742(01)00054-0
  18. Wall ME, Wani MC, Manikumar G, Abraham P, Taylor H, Hughes TJ, Warner J, McGiveney R. Plant antimutagenic agents. 2. Flavonoids. J. Nat. Prod. 51: 1084-1091 (1988) https://doi.org/10.1021/np50060a006
  19. Imamura Y, Migita T, Uriu Y, Otagiri M, Okawara T. Inhibitory effects of flavonoids on rabbit heart carbonyl reductase. J. Biochem.-Tokyo 127: 653-658 (2000)
  20. Matsuda H, Ando S, Kato T, Morikawa T, Yoshikawa M. Inhibitors from the rhizomes of Alpinia officinarum on production of nitric oxide in lipopolysaccharide-activated macrophages and the structural requirements of diaryJheptanoids for the activity. Bioorgan. Med. Chem. 14: 138-142 (2006) https://doi.org/10.1016/j.bmc.2005.08.003
  21. De Monbrison F, Maitrejean M, Latour C, Bugnazet F, Peyron F, Barron D, Picot S. In vitro antimalarial activity of flavonoid derivatives dehydrosilybin and 8-(1;1)-DMA-kaempferide. Acta Trop. 97: 102-107 (2006) https://doi.org/10.1016/j.actatropica.2005.09.004
  22. Simoes LMC, Gregorio LE, Da Silva Filho AA, de Souza ML, Azzolini AECS, Bastos JK, Lucisano-Valim YM. Effect of Brazilian green propolis on the production of reactive oxygen species by stimulated neutrophils. J. Ethnopharmacol. 94: 59-65 (2004) https://doi.org/10.1016/j.jep.2004.04.026
  23. Curir P, Dolci M, Lanzotti, V, Taglialatela-Scafati O. Kaempferide triglycoside: A possible factor of resistance of carnation (Dianthus caryophyllus) to Fusarium oxysporum f. sp. dianthi. Phytochemistry 56: 717-721 (2001) https://doi.org/10.1016/S0031-9422(00)00488-X
  24. Ohkawa H, Ohishi N, Yagi, K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351-358 (1979) https://doi.org/10.1016/0003-2697(79)90738-3
  25. Popravko SA, Gurevich AI, Kolosov MN. Flavonoid components of propolis. Khim. Prir. Soedin+ 5: 476-482 (1969)
  26. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629-1632 (1986) https://doi.org/10.1126/science.3487117
  27. Hayman S, Kinoshita JH. Isolation and properties of Lens aldose reductase. J. BioI. Chem. 240: 877-882 (1965)
  28. Sato S, Kador PF. Inhibition of aldehyde reductase by aldose reductase inhibitors. Biochem. Pharmacol. 40: 1033-1042 (1990) https://doi.org/10.1016/0006-2952(90)90490-C
  29. Kim SJ, Kim GH. Quantification of quercetin in different parts of onion and its DPPH radical scavenging and antibacterial activity. Food Sci. Biotechnol. 15: 39-43 (2006)
  30. Wee JH, Moon JH, Eun JB, Chung JH, Kim YG, Park KH. Isolation and identification of antioxidants from peanut shells and the relationship between structure and antioxidant activity. Food Sci. Biotechnol. 16: 116-122 (2007)
  31. Gomez-Sanchez A, Maya I, Hermosin I. Reaction of amino sugars with malondialdehyde. Carbohyd. Res. 200: 167-180 (1990) https://doi.org/10.1016/0008-6215(90)84188-Z
  32. Monnier VM. Nonenzymatic glycosylation, the Maillard reaction and aging process. J. Gerontol. 45: 105-111 (1990) https://doi.org/10.1093/geronj/45.4.B105
  33. Shih CC, Wu YW, Lin WC. Antihyperglycemic and antioxidant properties of Anoectochilus formosanus in diabetic rats. Clin. Exp. Pharmacol. 29: 684-688 (2002) https://doi.org/10.1046/j.1440-1681.2002.03717.x
  34. Ryu JK, Lee T, Kim DJ. Free radical scavenging activity of Korean red ginseng for erectile dysfunction in non insulin dependent diabetes mellitus rats. Urology 65: 611-615 (2005) https://doi.org/10.1016/j.urology.2004.10.038
  35. Ravi K, Ramachandran B, Subramanian S. Effect of Eugenia jambolana seed kernel on antioxidant defense system in streptozotocin-induced diabetes in rats. Life Sci. 75: 2717-2731 (2004) https://doi.org/10.1016/j.lfs.2004.08.005